From cutting-edge keynotes and bold tech showcases to pitch competitions and cross-disciplinary collaboration, plan your front-row seat to the next era of cardiovascular innovation.
Want to see everything in one place? Download the full HRX Live 2025 Program to explore session times, speakers, lounges, and can’t miss experiences happening September 4-6 in Atlanta.
08:00 AM (EDT)
– 09:10 AM (EDT)
Innovation Stage
Jonathan Piccini | Shlomo Shpun | Sabine Ernst | Vadim Fedorov | Philip Haeusser | Mélèze Hocini | Jerome Kalifa | Devi G. Nair | Sanjiv Narayan | Usha Tedrow
Click on the session title to learn more and see a full agenda for this Innovation Summit section.
09:10 AM (EDT)
– 10:15 AM (EDT)
Innovation Stage
Devi Nair | Sabine Ernst | Holger Friedrich | E. Kevin Heist | Gerhard Hindricks | H. Immo Lehmann | Moussa Mansour | Vivek Y. Reddy | Kalyanam Shivkumar
Click on the session title to learn more and see a full agenda for this Innovation Summit section.
01:00 PM (EDT)
– 01:45 PM (EDT)
Main Stage 1
Kris Shah | Suneet Mittal
Kris Shah, former President of Baylis Medical and a driving force behind one of Canada’s most influential MedTech success stories, joins Dr. Suneet Mittal for a main tent conversation at HRX 2025. Together, they will explore how innovation can be intentionally cultivated—from early-stage ideation to global scale. Drawing from his leadership at Baylis Medical, Kris will share how he created an environment that empowered engineers and clinicians to challenge convention, embraced failure as a learning tool, and ultimately brought disruptive cardiovascular technologies to market. Attendees will gain insight into the strategic, cultural, and operational levers needed to sustain innovation in a highly regulated, risk-averse industry. Whether you’re a founder, physician, or executive, this session offers a blueprint for how to lead boldly and innovate with purpose.
02:00 PM (EDT)
– 02:45 PM (EDT)
Main Stage 2
Mintu Turakhia | Shih-An Chen | Maulik Majmudar | Nagesh Rangappan | Venk Varadan | Jeffrey Wessler
This session explores how AI-driven innovations are transforming atrial fibrillation (AF) management, from prevention to long-term care. Experts will discuss AI-powered digital education, solutions for early intervention, and technology’s role in addressing key risk factors like obesity, sleep apnea, and exercise. Is AI the game-changer in achieving sustainable AF care, or just another trend? Join us to find out.
02:00 PM (EDT)
– 02:45 PM (EDT)
Main Stage 1
Aileen Ferrick | Jessica Mullenix | Carissa Pistilli | Yekaterina Spivak | Julie Thomas | Amy Tucker | Rebecca Yapejian
In this session, we will delve into the evolving landscape of remote monitoring, addressing the increasing challenges associated with managing vast amounts of data collected from wearables, implantables, and external monitoring devices. We will explore the complexities of integrating data across diverse platforms, with a particular focus on overcoming interoperability barriers.
02:45 PM (EDT)
– 03:30 PM (EDT)
Main Stage 2
Brynn Dechert-Crooks | Benjamin Hale | Jamie Harris | Lisa Roelle | John Triedman | Nicholas Von Bergen
From life-changing interventions to emotional uncertainties, how does cardiac technology shape the journey of children and young adults with arrhythmias? This session explores the evolving role of electrophysiology (EP) in pediatrics, the impact of cutting-edge devices, and the patient experience—balancing fear, hope, and the promise of innovation. Are we maximizing technology’s potential, or is is there more to uncover in improving outcomes and quality of life for young patients?
03:45 PM (EDT)
– 04:30 PM (EDT)
Main Stage 2
Dominic Abrams | Vassilios Bezzerides | Gabriel Brooks | Samuel Hall | Andrew Krahn | Cain McClary | David Milan
Inherited arrhythmia syndromes and cardiomyopathies pose a significant clinic challenge, with suboptimal treatment and a large unmet need. Over the last decade several new therapies have been developed which target the underlying genetic and molecular causes of these conditions, and many are progressing from pre-clinical research to clinical trials. These discoveries offer a potential paradigm shift in treatment strategies and quality of life for patients. This panel focused on novel genetic and molecular therapies for inherited arrhythmia syndromes and arrhythmogenic cardiomyopathies will bring together experts with a broad range of experience including venture capital, clinicians, translational scientists, and biotech. The session will address a wide range of topics from lab discovery to commercialization.
03:45 PM (EDT)
– 04:30 PM (EDT)
Innovation Stage
Natalia Trayanova | Patrick Boyle | Jonathan Chrispin | Tanmay Gokhale | Liat Tsoref
Digital twins offer the promise to develop, test, and validate potential personalized solutions for heart rhythm care that are unique to a given individual and their myocardial substrate. Early studies have been promising. However, there are significant challenges from several different areas including operational, computational, and efficacy. This session will engage in discussing whether digital twins will become a foundational core of EP care or remain a fantasy.
03:45 PM (EDT)
– 04:30 PM (EDT)
Main Stage 1
Daniel Morin (Moderator) | Victor Abrich | Yaariv Khaykin | Bobak Mosadegh | Nobunari Tomura | Bryant Wyatt
The Top 5 scoring AbstracX Researchers will share their research.
04:30 PM (EDT)
– 05:15 PM (EDT)
Main Stage 1
Amin Al-Ahmad | Luigi Di Biase | Kenneth Ellenbogen | Christoph Hennersperger | Stephen Metz | Binh C. Tran | Roy Urman
There is an unprecedented surge in innovation surrounding intracardiac ultrasound and its integration into electrophysiologic care. Future iterations of 4-D intracardiac ultrasound, next-generation integration into mapping systems, and the use of ultrasound for therapeutic purposes all have the potential to significantly change practice. This session will review these key innovations and how they may improve care in the EP laboratory.
04:30 PM (EDT)
– 05:15 PM (EDT)
Innovation Stage
Dhanunjaya R. Lakkireddy | Ilyas Colombowala | Hawkins Gay | Michael Katz | Joshua Lampert
From dictation software to full-blown natural language processing assistants, AI-based documentation tools promise to free clinicians from the tedium of charting. Physician burnout is on the rise—can AI-driven documentation help turn the tide? Strategies for successful change management, physician buy-in, and ongoing system optimization will be highlighted. How do we ensure data accuracy, privacy, and seamless integration into diverse electronic health records? Panelists will discuss the practical implementation of AI-assisted documentation and patient communication, while maintaining patient-centered care.
04:30 PM (EDT)
– 05:15 PM (EDT)
Main Stage 2
David Slotwiner | Curtis Harper | George Stuart Mendenhall | Craig Reister | Jill Schaeffer | Paul Steiner | James E. Tcheng | Andrew Winburn
This session explores how AI integration, EMR advancements, and remote monitoring can enhance physician decision-making, streamline workflows, and improve patient care. Panelists will discuss the impact of AI on billing and physician hours, the role of device-driven insights in heart failure management, and how RNs and APPs contribute to effective communication and data management. Join us for an insightful discussion on leveraging technology to optimize clinical efficiency and patient outcomes.
08:45 AM (EDT)
– 09:30 AM (EDT)
Main Stage 1
Doron Harlev | Jonathan Piccini
Doron Harlev, the CEO of Mount Heart Labs, prior VP of Medtronic, and founder and CEO of Affera, and Rhythmia Medical has been one of the key forces of change and innovation in the field of catheter ablation. He will join Dr. Jonathan Piccini for a main tent conversation at HRX 2025. Doron will share his journey of high-impact innovation, including his experiences in developing and refining reproducible high-density mapping and his work in developing pulsed field ablation in a very unique lattice catheter platform. Doron will share how he targeted key unmet needs in the field by solving complex problems with elegant solutions. Attendees will gain insight into the key processes inherent to innovation, idea generation, development, testing, iteration, and implementation. Attendees will also gain insight into the next big challenges and innovation targets in the field of cardiac electrophysiology.
09:45 AM (EDT)
– 10:30 AM (EDT)
Main Stage 2
Jonathan Piccini | Marat Fudim | Sanjiv Narayan | Stavros Stavrakis | Kalyanam Shivkumar
The autonomic nervous system is known to play a critical role in the initiation and/or triggering of many arrhythmias, including atrial fibrillation. Autonomic therapies have moved well-beyond isolated ablation of cardiac ganglionated plexi. This session will review the innovations that have expanded autonomic therapies, including tragus stimulation, renal sympathetic denervation, and future innovations for additional interventions.
10:30 AM (EDT)
– 11:15 AM (EDT)
Main Stage 2
Mikhael El-Chami | Neal Bhatia | Janet K. Han | Anne Kroman | Kathryn Hilpisch
This session will detail the possibilities, potential technologies, and likely pathways for permanent pacing in the future. Specifically, this session will explore next generation pacing technologies, including but not limited to advances in leadless pacing, micro-devices, new epicardial pacing interventions, pacing for HFpE, and physiologic atrial pacing.
12:30 PM (EDT)
– 01:15 PM (EDT)
Main Stage 2
Jeffrey Winterfield | Sotirios Nedros | Ravi Ranjan | Harikrishna Tandri | Usha Tedrow | Natalia Trayanova
Innovations in imaging—ranging from real-time 3D/4D echo, advanced CT mapping to cardiac MRI—are reshaping electrophysiology. This session explores how novel visualization tools and AI-powered image processing can guide complex procedures while improving patient safety and outcomes.
12:30 PM (EDT)
– 01:15 PM (EDT)
Main Stage 1
Avi Fischer | Daniel Cantillon | Howard R. Levin | Jennifer N. Avari Silva | Alicia C. Rodriguez | Mintu Turakhia
Not all innovation is successful. Many potential innovations fail in the pre-clinical or early testing phases – often for common reasons. This session will discuss the potential pitfalls in device development and how innovators can navigate these challenges with greater confidence by avoiding mistakes and missteps. The panel will discuss their “dream” innovations that didn’t come to fruition – and what they learned.
01:15 PM (EDT)
– 02:00 PM (EDT)
Main Stage 2
Paul Wang | Julia Berzhanskaya | Andrea Russo | J. Peter Weiss | Khaldoun Tarakji | Liat Tsoref
EP Collaboratory to share efforts between industry and early stage companies to promote EFS within the US to increase patient access to new technologies and to support device innovation.
01:15 PM (EDT)
– 02:00 PM (EDT)
Innovation Stage
Steven Lubitz | Kristin Bova Campbell | Mina K. Chung | Shilpi Epstein | Dan Musat | Rod Passman
Catheter ablation has become the dominant form of therapeutic intervention for cardiac arrhythmias. However, preclinical development of new antiarrhythmic drugs is very robust. These new molecular entities are not limited to antagonism of membrane active ion channels, but target additional mechanisms of arrhythmogenesis. These drugs, their targets, and their potential ability to improve and disrupt current care paradigms will be reviewed in this session.
02:00 PM (EDT)
– 02:45 PM (EDT)
Main Stage 2
Sanjiv Narayan | Isabel Deisenhofer | Sabine Ernst | Mitchell Faddis | Shlomo Shpun | Jennifer N. Avari Silva
Self-driving cars, remote control of drones, and self-navigating planes are all current realities. However, mapping and ablation of cardiac arrhythmias is a completely human and labor-intensive endeavor, despite many advances over the years. This session will discuss the key barriers and potential solutions that may enable remote control of mapping and ablation as well as semi-autonomous systems for mapping and ablation.
03:00 PM (EDT)
– 03:45 AM (EDT)
Main Stage 2
Julie Shea (Moderator) | Advay Bhatt | Na Le Dang | Geoffroy Napon | Rachita Navara | Christopher Porterfield
This moderated AbstracX session features presentations from four selected authors, each showcasing innovative research and insights. Join us for a dynamic exchange of ideas and expert discussion.
03:00 PM (EDT)
– 03:45 PM (EDT)
Main Stage 1
Vivek Y. Reddy | Isabel Deisenhofer | Thomas Deneke | Brendan Koop | Steven Mickelsen | Mark Stewart
By the time of HRX 2025, pulsed field ablation will have been clinically available in the US for more than a year and a half. While first-gen systems have brought notable changes to EP, these first-generation systems only represent the very beginning of PFA. This session will focus on discussion of the key developments and advances for next generation PFA technologies, including advances in pulse sequences, catheter design, integration with electroanatomic mapping, and patient- and anatomic-specific custom lesion formation.
03:45 PM (EDT)
– 04:30 PM (EDT)
Main Stage 2
Marat Fudim | Mohamed Abou-Alam | Demilade Adedinsewo | Jay Edelberg | Sarah Smith | Ajay Srivastava
As healthcare shifts toward proactive interventions, AI holds the promise of detecting heart failure before overt symptoms appear. In this session, experts will discuss how machine learning and big-data analytics can arm clinicians with real-time insights to intervene at the earliest sign of HF decompensation. Attendees will gain an understanding of predictive models, novel monitoring tools, and the challenges involved in implementing such technologies on a broad scale.
03:45 PM (EDT)
– 04:30 PM (EDT)
Main Stage 1
Krishna Pundi | Derek Exner | Matthew Kalscheur | Grant McQueen | Stuart Schecter | Deepthy Varghese
This moderated AbstracX session features presentations from four selected authors, each showcasing innovative research and insights. Join us for a dynamic exchange of ideas and expert discussion.
04:45 PM (EDT)
– 05:30 PM (EDT)
Main Stage 2
Jennifer N. Avari Silva | Daniel Cooper | Sabine Ernst | J. Peter Weiss | Paul Zei
What’s next in the evolution of cardiac ablation technology? This session explores whether ease of use will translate into superior outcomes, the potential of novel energy sources, and the role of robotics, AR, and VR in procedural automation. Experts will also discuss the promise of computational modeling in personalizing ablation strategies—are we truly on the brink of precision ablation, or is clinical translation still a work in progress?
08:00 AM (EDT)
– 08:45 AM (EDT)
Main Stage 2
Sana Al-Khatib | Martin Burke | Chad Bonhomme | David McManus | Deepak Padmanabhan | Niraj Varma
Innovation in cardiology remains a central driving force to better patient care. This session explores how emerging technologies provide both opportunities and challenges to execute.
08:00 AM (EDT)
– 08:45 AM (EDT)
Innovation Stage
Adrian Hernandez | Avi Fischer | Ishu Rao | Leyla Sabet
This session will highlight the challenges, current best practices, and how innovation will impact regulatory science, with a focus on first-in-human device trials. The session will highlight shared and unique challenges in different regions of the world, including Asia, Europe, and North America. Attendees will be armed with a better understanding of the key barriers and facilitators for successful first-in-human trials.
08:45 AM (EDT)
– 09:30 AM (EDT)
Main Stage 2
Jagmeet Singh | Ricky Bloomfield | Derek Exner | Srinivasan Murali | Uma Srivatsa | Mintu Turakhia
The advent of multiple sensors in wearables begins to provide clinicians with a treasure trove of data of unknown impact and usefulness. This session will examine tech and the patient experience of employing it.
09:45 AM (EDT)
– 10:30 AM (EDT)
Main Stage 1
Atul Gupta, MD | Jennifer N. Avari Silva
Physicians are uniquely positioned to identify unmet needs in patient care and lead the development of transformative solutions. This session explores how clinicians can move from recognizing challenges at the bedside to driving innovations in cardiovascular medicine. Hear from physician-innovators who have successfully navigated the path from concept to implementation—collaborating with engineers, entrepreneurs, and industry partners along the way. Attendees will gain practical insights into cultivating an innovation mindset, building interdisciplinary teams & value propositions, and translating clinical expertise into real-world advancements that improve outcomes.
10:45 AM (EDT)
– 11:30 AM (EDT)
Main Stage 2
James O’Hara | Janet K. Han | Lisa Roelle | Heather Ross | Lauren Rousseau | Prashanthan Sanders
We will discuss key issues surrounding interoperability and integration, exploring innovative solutions for seamless data flow across multiple monitoring systems. Additionally, we will evaluate the role of AI to support clinical decision-making, enhancing both patient outcomes and operational efficiency. Join us to explore the future of remote monitoring and data management, and how innovations in this field are shaping the future of healthcare
10:45 AM (EDT)
– 11:30 AM (EDT)
Main Stage 1
Paul Varosy | Myrte Bartheis | Ibrahim Karabayir | Yingshuo Liu | Krishna Pundi
This moderated AbstracX session features presentations from four selected authors, each showcasing innovative research and insights. Join us for a dynamic exchange of ideas and expert discussion.
Secure your spot today and immerse yourself in an unforgettable experience of growth, innovation, and collaboration. Register now to access world-class expertise and cutting-edge insights for a brighter, stronger future in EP.
Please use your HRS login for registration. If you do not have one, you can create one in just a few minutes.
